HealthEquity, Inc. announced its financial results for the third quarter ended October 31, 2025.
Revenue increased by 7% to $322.2 million during the quarter, with notable growth in net income per diluted share and non-GAAP net income per diluted share.
Total HSA Assets reached $34.4 billion, showcasing a 15% growth.
The company returned $93.7 million to shareholders through stock repurchases.
HealthEquity further reduced HSA cash repricing risk with a $2.25 billion 5-year Treasury bond hedge at 3.94%.
Revenue Growth
Revenue increased by 7% to $322.2 million, driven by strong performance in service, custodial, and interchange revenue categories.
Net Income Improvement
Net income per diluted share rose to $0.59 from $0.06 one year ago, and non-GAAP net income per diluted share increased by 29% to $1.01.
HSA Assets Expansion
Total HSA Assets grew by 15% to $34.4 billion, reflecting the company's ability to attract and retain HSA accounts.
Shareholder Returns
HealthEquity returned $93.7 million to shareholders through stock repurchases during the third quarter.
Risk Management
The company reduced HSA cash repricing risk by implementing a $2.25 billion 5-year Treasury bond hedge at a rate of 3.94%.
- The financial results demonstrate HealthEquity's sustained growth trajectory and successful strategic initiatives.
- The increased revenue, net income, and HSA assets position the company favorably in the healthcare consumer-directed benefits market.
- The focus on reducing risk and enhancing shareholder value showcases HealthEquity's commitment to long-term sustainability and profitability.
HealthEquity's record third-quarter performance underscores its position as a leader in administering health savings accounts and consumer-directed benefits. The company's growth in revenue, net income, and HSA assets reflects its commitment to financial excellence and innovation in the healthcare industry.